smoking and glp 1 Semaglutide May Ease Tobacco Use, Study Suggests Not just obesity: GLP-1 receptor

doi: 10.1016/S2213-8587(17)30092-X 60 ArodaVRBainSCCariouBPiletiMRoseLAxelsenMet al

[DOI] [PubMed] [Google Scholar] 4.Mcintyre N, Holdsworth CD, Turner DS

Protocol 1: the gentle start (for GI-sensitive individuals) Goal: Minimize side effects completely while building to a therapeutic dose Best for: People with histories of medication sensitivity, IBS, acid reflux, or those who tried standard tirzepatide and could not tolerate it Complete schedule: Weeks 1-2: 0.125 mg weekly Weeks 3-4: 0.25 mg weekly Weeks 5-6: 0.5 mg weekly Weeks 7-8: 0.75 mg weekly Weeks 9-10: 1.0 mg weekly Weeks 11-14: 1.5 mg weekly Weeks 15-18: 2.0 mg weekly Weeks 19-22: 2.5 mg weekly Weeks 23-26: 5.0 mg weekly Time to therapeutic dose: 22-26 weeks Expected results: Minimal GI discomfort, gradual appetite reduction beginning around weeks 7-10, meaningful weight loss starting around weeks 15-18 This protocol takes nearly six months to reach 5 mg, but for someone who previously abandoned treatment due to side effects, six months on treatment beats three weeks of misery followed by quitting

Why Its More Than Weight Loss Yes, you may lose weight

A well-designed patient portal is where these interactions happen, and it directly influences outcomes and long-term retention

Evidence suggests benefits on weight and cardiometabolic risk